The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular predictors of response among patients with MMRd tumors treated on NCI-MATCH Arm Z1D.
 
Jonathan Daniel Schoenfeld
Stock and Other Ownership Interests - Immunitas
Consulting or Advisory Role - ACI Clinical; Astellas Pharma; Debiopharm Group; Genentech; Immunitas; Stimit
Research Funding - Bristol-Myers Squibb; Merck; Regeneron
Expert Testimony - Heidell, Pittoni, Murphy & Bach; Kline & Specter P.C.
 
Nilofer Saba Azad
Consulting or Advisory Role - AstraZeneca; Helsinn Therapeutics/QED Therapeutics; Incyte; Merck; Mirati Therapeutics; QED Therapeutics
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); AtlasMedx (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); EMD Serono; Genentech (Inst); Incyte (Inst); Intensity Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Syndax (Inst)
 
Jennifer Lee
No Relationships to Disclose
 
Jacob Gross
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - 3D Medicines; Array BioPharma; Bristol-Myers Squibb; Gritstone Bio; Janssen; Janssen; MedImmune; Merck; Novartis; Pfizer; Pfizer; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Katrina Kao
No Relationships to Disclose
 
Anna Steinfeld
No Relationships to Disclose
 
Donna Brunnquell
No Relationships to Disclose
 
Xiangning Bu
No Relationships to Disclose
 
Ping Guan
No Relationships to Disclose
 
Jason L. Weirather
No Relationships to Disclose
 
Kathleen L. Pfaff
No Relationships to Disclose
 
Srin Ranasinghe
No Relationships to Disclose
 
Victoria Wang
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); BBI Healthcare (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Lilly/ImClone (Inst); Minneamrita Therapeutics (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); syndax (Inst); Taiho Pharmaceutical (Inst)
Expert Testimony - Dai-ichi Sankyo; Lilly
 
Catherine J. Wu
Stock and Other Ownership Interests - Biontech; Biontech (I)
Research Funding - Pharmacyclics/Janssen
 
Scott J. Rodig
Leadership - Immunitas
Stock and Other Ownership Interests - Immunitas
Honoraria - Bristol-Myers Squibb; Perkin Elmer
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Affimed Therapeutics; Bristol-Myers Squibb; Kite, a Gilead company; Merck
Patents, Royalties, Other Intellectual Property - Patent pending for use of Anti-galectin1 antibodies for diagnostic use.
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
David R. Patton
No Relationships to Disclose
 
Lyndsay Harris
Patents, Royalties, Other Intellectual Property - Philips Healthcare